DMS Imaging (XBRU:ALIMG) Days Payable : 97.79 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is DMS Imaging Days Payable?

DMS Imaging's average Accounts Payable for the six months ended in Dec. 2023 was €7.49 Mil. DMS Imaging's Cost of Goods Sold for the six months ended in Dec. 2023 was €13.98 Mil. Hence, DMS Imaging's Days Payable for the six months ended in Dec. 2023 was 97.79.

The historical rank and industry rank for DMS Imaging's Days Payable or its related term are showing as below:

XBRU:ALIMG' s Days Payable Range Over the Past 10 Years
Min: 80.8 Med: 99.38 Max: 61198.33
Current: 96.94

During the past 12 years, DMS Imaging's highest Days Payable was 61198.33. The lowest was 80.80. And the median was 99.38.

XBRU:ALIMG's Days Payable is ranked worse than
60.03% of 718 companies
in the Biotechnology industry
Industry Median: 152.29 vs XBRU:ALIMG: 96.94

DMS Imaging's Days Payable increased from Dec. 2022 (74.70) to Dec. 2023 (97.79). It may suggest that DMS Imaging delayed paying its suppliers.

DMS Imaging Days Payable Historical Data

The historical data trend for DMS Imaging's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DMS Imaging Days Payable Chart

DMS Imaging Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

80.80

104.07

94.68

DMS Imaging Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															-	77.58	74.70	98.39	97.79

Competitive Comparison of DMS Imaging's Days Payable

For the Biotechnology subindustry, DMS Imaging's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DMS Imaging's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, DMS Imaging's Days Payable distribution charts can be found below:

* The bar in red indicates where DMS Imaging's Days Payable falls into.

DMS Imaging Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

DMS Imaging's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (6.57	+	7.465)	/	2 )	/	27.053	*	365
=	7.0175					/	27.053	*	365
=	94.68

DMS Imaging's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (7.521	+	7.465)	/	2 )	/	13.984	*	365 / 2
=	7.493					/	13.984	*	365 / 2
=	97.79

DMS Imaging Days Payable Related Terms

Thank you for viewing the detailed overview of DMS Imaging's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

DMS Imaging (XBRU:ALIMG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (XBRU:ALIMG) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

AS0:Germany

Address

7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website

https://www.dms-imaging.com

DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (XBRU:ALIMG) Headlines

No Headlines